{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:34:48Z","timestamp":1790109288950,"version":"4.0.1"},"reference-count":256,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40257-026-01009-2","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:14:04Z","timestamp":1771524844000},"page":"363-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-1276","authenticated-orcid":false,"given":"Caitlin A.","family":"Kearney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Brinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carli Needle","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek E.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie J.","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Coric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liezel A.","family":"Gener-Pangilinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Antonio","family":"Lasheras-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen I.","family":"Lo Sicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"1009_CR1","first-page":"15","volume":"149","author":"BM Piraccini","year":"2014","unstructured":"Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149(1):15\u201324.","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"1009_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40257-018-0405-2","volume":"20","author":"DH Marks","year":"2019","unstructured":"Marks DH, Penzi LR, Ibler E, Manatis-Lornell A, Hagigeorges D, Yasuda M, et al. The medical and psychosocial associations of alopecia: recognizing hair loss as more than a cosmetic concern. Am J Clin Dermatol. 2019;20(2):195\u2013200.","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"1009_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2021.2196","volume":"157","author":"CH Huang","year":"2021","unstructured":"Huang CH, Fu Y, Chi CC. Health-related quality of life, depression, and self-esteem in patients with androgenetic alopecia: a systematic review and meta-analysis. JAMA Dermatol. 2021;157(8):963\u201370.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1009_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/0190-9622(93)70223-G","volume":"29","author":"TF Cash","year":"1993","unstructured":"Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29(4):568\u201375.","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdin.2023.07.005","volume":"13","author":"S Ntshingila","year":"2023","unstructured":"Ntshingila S, Oputu O, Arowolo AT, Khumalo NP. Androgenetic alopecia: an update. JAAD Int. 2023;13:150\u20138.","journal-title":"JAAD Int"},{"key":"1009_CR6","unstructured":"FDA. FoLix system approval. 2024; Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K242349.pdf.  Accessed 2 Aug 2025."},{"issue":"4","key":"1009_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.fsc.2018.06.003","volume":"26","author":"AM Park","year":"2018","unstructured":"Park AM, Khan S, Rawnsley J. Hair biology: growth and pigmentation. Facial Plast Surg Clin North Am. 2018;26(4):415\u201324.","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"1009_CR8","volume":"4","author":"I Brajac","year":"2014","unstructured":"Brajac I, Vi\u010di\u0107 M, Peri\u0161a D, Ka\u0161telan M. Human hair follicle: an update on biology and perspectives in hair growth disorders treatment. Hair Ther Transplant. 2014;4(1):115.","journal-title":"Hair Ther Transplant"},{"issue":"2","key":"1009_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.23316","volume":"32","author":"SL Koch","year":"2020","unstructured":"Koch SL, Tridico SR, Bernard BA, Shriver MD, Jablonski NG. The biology of human hair: a multidisciplinary review. Am J Hum Biol. 2020;32(2):e23316.","journal-title":"Am J Hum Biol"},{"issue":"3","key":"1009_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/jcm12030893","volume":"12","author":"N Natarelli","year":"2023","unstructured":"Natarelli N, Gahoonia N, Sivamani RK. Integrative and mechanistic approach to the hair growth cycle and hair loss. J Clin Med. 2023;12(3):893.","journal-title":"J Clin Med"},{"issue":"21","key":"1009_CR11","first-page":"377","volume":"113","author":"H Wolff","year":"2016","unstructured":"Wolff H, Fischer TW, Blume-Peytavi U. The diagnosis and treatment of hair and scalp diseases. Dtsch Arztebl Int. 2016;113(21):377\u201386.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"1009_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jaad.2023.08.028","volume":"89","author":"MG Buontempo","year":"2023","unstructured":"Buontempo MG, Sperling LC, Alhanshali L, Shapiro J, Lo Sicco K. Establishing baselines of hair density measurements: variations across ethnicity, scalp region, and measurement techniques: a systematic review. J Am Acad Dermatol. 2023;89(6):1294\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.det.2012.08.006","volume":"31","author":"T Breitkopf","year":"2013","unstructured":"Breitkopf T, Leung G, Yu M, Wang E, McElwee KJ. The basic science of hair biology: what are the causal mechanisms for the disordered hair follicle? Dermatol Clin. 2013;31(1):1\u201319.","journal-title":"Dermatol Clin"},{"issue":"1","key":"1009_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jvc2.86","volume":"2","author":"WC Chang","year":"2023","unstructured":"Chang WC, Chen KY, Cheng SY, Hsu CK, Yang CC. Mapping the hair density, thickness, and volume in normal and androgenetic alopecia subjects with the digital microscope. JEADV Clin Pract. 2023;2(1):174\u20138.","journal-title":"JEADV Clin Pract"},{"issue":"2","key":"1009_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","volume":"144","author":"MP Birch","year":"2001","unstructured":"Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144(2):297\u2013304.","journal-title":"Br J Dermatol"},{"issue":"11","key":"1009_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","volume":"68","author":"OT Norwood","year":"1975","unstructured":"Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359\u201365.","journal-title":"South Med J"},{"issue":"2","key":"1009_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF03401334","volume":"13","author":"ML Batrinos","year":"2014","unstructured":"Batrinos ML. The endocrinology of baldness. Hormones (Athens). 2014;13(2):197\u2013212.","journal-title":"Hormones (Athens)"},{"issue":"15","key":"1009_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155342","volume":"21","author":"M Grymowicz","year":"2020","unstructured":"Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, et al. Hormonal effects on hair follicles. Int J Mol Sci. 2020;21(15):5342.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.semcdb.2007.02.004","volume":"18","author":"VA Randall","year":"2007","unstructured":"Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol. 2007;18(2):274\u201385.","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"1009_CR20","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1210\/jc.2018-02548","volume":"104","author":"E Carmina","year":"2019","unstructured":"Carmina E, Azziz R, Bergfeld W, Escobar-Morreale HF, Futterweit W, Huddleston H, et al. Female pattern hair loss and androgen excess: a report from the multidisciplinary androgen excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1009_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","volume":"80","author":"A Bienenfeld","year":"2019","unstructured":"Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80(6):1497\u2013506.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR22","first-page":"13","volume":"42","author":"B Riedel-Baima","year":"2008","unstructured":"Riedel-Baima B, Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul. 2008;42(1):13\u20136.","journal-title":"Endocr Regul"},{"issue":"3","key":"1009_CR23","first-page":"199","volume":"33","author":"M Nguyen","year":"2025","unstructured":"Nguyen M, Kraft S. Approaches to management of endocrine therapy-induced alopecia in breast cancer patients. Support Care Cancer. 2025;33(3):199.","journal-title":"Support Care Cancer"},{"key":"1009_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","volume":"499","author":"JL Zhu","year":"2019","unstructured":"Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142\u20138.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1009_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1095\/biolreprod.111.092593","volume":"85","author":"GL Hammond","year":"2011","unstructured":"Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011;85(3):431\u201341.","journal-title":"Biol Reprod"},{"key":"1009_CR26","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.2147\/CCID.S423177","volume":"16","author":"Q Chen","year":"2023","unstructured":"Chen Q, Tao Q, Zhu Q, Zhu J, Du X. Association between trichoscopic features and serum hormone levels and vitamin D concentration in patients with androgenetic alopecia in Eastern China: a cross-sectional study. Clin Cosmet Investig Dermatol. 2023;16:2547\u201355.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"21","key":"1009_CR27","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.3390\/ijms21218191","volume":"21","author":"X Qu","year":"2020","unstructured":"Qu X, Donnelly R. Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int J Mol Sci. 2020;21(21):8191.","journal-title":"Int J Mol Sci"},{"issue":"287","key":"1009_CR28","first-page":"323","volume":"48","author":"K Kozicka","year":"2020","unstructured":"Kozicka K, Lukasik A, Pastuszczak M, Jaworek A, Spalkowska M, Klosowicz A, et al. Is hormone testing worthwhile in patients with female pattern hair loss? Pol Merkur Lekarski. 2020;48(287):323\u20136.","journal-title":"Pol Merkur Lekarski"},{"issue":"1","key":"1009_CR29","first-page":"3","volume":"35","author":"SK Henne","year":"2023","unstructured":"Henne SK, N\u00f6then MM, Heilmann-Heimbach S. Male-pattern hair loss: comprehensive identification of the associated genes as a basis for understanding pathophysiology. Med Genet. 2023;35(1):3\u201314.","journal-title":"Med Genet"},{"issue":"8","key":"1009_CR30","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1038\/ncomms14694","volume":"8","author":"S Heilmann-Heimbach","year":"2017","unstructured":"Heilmann-Heimbach S, Herold C, Hochfeld LM, Hillmer AM, Nyholt DR, Hecker J, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nat Commun. 2017;8(8):14694.","journal-title":"Nat Commun"},{"issue":"12","key":"1009_CR31","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1096\/fj.04-2293fje","volume":"19","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Kromminga A, Dunlop TW, Tychsen B, Conrad F, Suzuki N, et al. A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 2005;19(12):1710\u20132.","journal-title":"FASEB J"},{"issue":"1","key":"1009_CR32","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41467-017-01490-8","volume":"8","author":"N Pirastu","year":"2017","unstructured":"Pirastu N, Joshi PK, de Vries PS, Cornelis MC, McKeigue PM, Keum N, et al. GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. Nat Commun. 2017;8(1):1584.","journal-title":"Nat Commun"},{"issue":"8","key":"1009_CR33","first-page":"939","volume":"14","author":"J Lee","year":"2024","unstructured":"Lee J, Choi JE, Ha J, Kim Y, Lee C, Hong KW. Genetic differences between male and female pattern hair loss in a Korean population. Life (Basel). 2024;14(8):939.","journal-title":"Life (Basel)."},{"issue":"6","key":"1009_CR34","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1365-2133.2012.10877.x","volume":"166","author":"S Redler","year":"2012","unstructured":"Redler S, Brockschmidt FF, Tazi-Ahnini R, Drichel D, Birch MP, Dobson K, et al. Investigation of the male pattern baldness major genetic susceptibility loci AR\/EDA2R and 20p11 in female pattern hair loss. Br J Dermatol. 2012;166(6):1314\u20138.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1009_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jdermsci.2013.06.012","volume":"72","author":"S Redler","year":"2013","unstructured":"Redler S, Dobson K, Drichel D, Heilmann S, Wolf S, Brockschmidt FF, et al. Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci. 2013;72(2):186\u20138.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"1009_CR36","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/jid.2008.418","volume":"129","author":"Z Lu","year":"2009","unstructured":"Lu Z, Fischer TW, Hasse S, Sugawara K, Kamenisch Y, Krengel S, et al. Profiling the response of human hair follicles to ultraviolet radiation. J Investig Dermatol. 2009;129(7):1790\u2013804.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"1009_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/ijt.ijt_59_21","volume":"14","author":"Y Kavadya","year":"2022","unstructured":"Kavadya Y, Mysore V. Role of smoking in androgenetic alopecia: a systematic review. Int J Trichol. 2022;14(2):41\u20138.","journal-title":"Int J Trichol"},{"key":"1009_CR38","doi-asserted-by":"publisher","DOI":"10.1201\/9781420078848","volume-title":"The chemical components of tobacco and tobacco smoke","author":"A Rodgman","year":"2008","unstructured":"Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. 1st ed. Boca Raton: CRC Press; 2008.","edition":"1"},{"issue":"11","key":"1009_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archderm.143.11.1401","volume":"143","author":"LH Su","year":"2007","unstructured":"Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol. 2007;143(11):1401\u20136.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1009_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000537745","volume":"10","author":"T Samra","year":"2024","unstructured":"Samra T, Lin RR, Maderal AD. The effects of environmental pollutants and exposures on hair follicle pathophysiology. Skin Appendage Disord. 2024;10(4):262\u201372.","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"1009_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaad.2021.11.013","volume":"86","author":"WR Heymann","year":"2022","unstructured":"Heymann WR. The inflammatory component of androgenetic alopecia. J Am Acad Dermatol. 2022;86(2):301\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaad.2021.09.040","volume":"86","author":"J Plante","year":"2022","unstructured":"Plante J, Valdebran M, Forcucci J, Lucas O, Elston D. Perifollicular inflammation and follicular spongiosis in androgenetic alopecia. J Am Acad Dermatol. 2022;86(2):437\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1590\/abd1806-4841.20175150","volume":"92","author":"PM Ramos","year":"2017","unstructured":"Ramos PM, Brianezi G, Martins ACP, Silva MGD, Marques MEA, Miot HA. Aryl hydrocarbon receptor overexpression in miniaturized follicles in female pattern hair loss. An Bras Dermatol. 2017;92(3):430\u20131.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"1009_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151444","volume":"11","author":"IA Sheikh","year":"2016","unstructured":"Sheikh IA, Turki RF, Abuzenadah AM, Damanhouri GA, Beg MA. Endocrine disruption: computational perspectives on human sex hormone-binding globulin and phthalate plasticizers. PLoS ONE. 2016;11(3):e0151444.","journal-title":"PLoS ONE"},{"issue":"271","key":"1009_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.116380","volume":"15","author":"A Mart\u00ednez-Ibarra","year":"2021","unstructured":"Mart\u00ednez-Ibarra A, Mart\u00ednez-Razo LD, MacDonald-Ramos K, Morales-Pacheco M, V\u00e1zquez-Mart\u00ednez ER, L\u00f3pez-L\u00f3pez M, et al. Multisystemic alterations in humans induced by bisphenol A and phthalates: Experimental, epidemiological and clinical studies reveal the need to change health policies. Environ Pollut. 2021;15(271):116380.","journal-title":"Environ Pollut"},{"issue":"2","key":"1009_CR46","first-page":"137","volume":"13","author":"AC Katoulis","year":"2015","unstructured":"Katoulis AC, Christodoulou C, Liakou AI, Kouris A, Korkoliakou P, Kaloudi E, et al. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges. 2015;13(2):137\u201342.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"1009_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3949\/ccjm.88a.20014","volume":"88","author":"NL Tamashunas","year":"2021","unstructured":"Tamashunas NL, Bergfeld WF. Male and female pattern hair loss: treatable and worth treating. Cleve Clin J Med. 2021;88(3):173\u201382.","journal-title":"Cleve Clin J Med"},{"issue":"10","key":"1009_CR48","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/archderm.141.10.1243","volume":"141","author":"A Rebora","year":"2005","unstructured":"Rebora A, Guarrera M, Baldari M, Vecchio F. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Arch Dermatol. 2005;141(10):1243\u20135.","journal-title":"Arch Dermatol"},{"issue":"11","key":"1009_CR49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1365-4632.2004.02034.x","volume":"43","author":"R Sinclair","year":"2004","unstructured":"Sinclair R. Chronic telogen effluvium or early androgenetic alopecia? Int J Dermatol. 2004;43(11):842\u20133.","journal-title":"Int J Dermatol"},{"issue":"6","key":"1009_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0190-9622(97)70099-9","volume":"37","author":"S Rand","year":"1997","unstructured":"Rand S. Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia? J Am Acad Dermatol. 1997;37(6):1021.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","volume":"152","author":"R Sinclair","year":"2005","unstructured":"Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466\u201373.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1009_CR52","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1590\/S0365-05962012000600010","volume":"87","author":"B Werner","year":"2012","unstructured":"Werner B, Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata\u2014part II. An Bras Dermatol. 2012;87(6):884\u201390.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"1009_CR53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5826\/dpc.0904a05","volume":"9","author":"A Alessandrini","year":"2019","unstructured":"Alessandrini A, Starace M, Bruni F, Brandi N, Baraldi C, Misciali C, et al. Alopecia areata incognita and diffuse alopecia areata: clinical, trichoscopic, histopathological, and therapeutic features of a 5-year study. Dermatol Pract Concept. 2019;9(4):272\u20137.","journal-title":"Dermatol Pract Concept."},{"issue":"4","key":"1009_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000155644","volume":"217","author":"S Inui","year":"2008","unstructured":"Inui S, Nakajima T, Itami S. Significance of dermoscopy in acute diffuse and total alopecia of the female scalp: review of twenty cases. Dermatology. 2008;217(4):333\u20136.","journal-title":"Dermatology"},{"issue":"3","key":"1009_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13555-025-01359-5","volume":"15","author":"G Rodr\u00edguez-Tamez","year":"2025","unstructured":"Rodr\u00edguez-Tamez G, Maskan-Bermudez N, Tosti A. Alopecia areata incognita: current evidence. Dermatol Ther (Heidelb). 2025;15(3):635\u201345.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"1009_CR56","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0041-1739256","volume":"54","author":"M Singh","year":"2021","unstructured":"Singh M, Acharya A. Overview and algorithmic approach to management of male and female pattern hair loss. Indian J Plast Surg. 2021;54(4):416\u201321.","journal-title":"Indian J Plast Surg"},{"issue":"6","key":"1009_CR57","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jaad.2019.12.056","volume":"85","author":"J Griggs","year":"2021","unstructured":"Griggs J, Tr\u00fceb RM, Gavazzoni Dias MFR, Hordinsky M, Tosti A. Fibrosing alopecia in a pattern distribution. J Am Acad Dermatol. 2021;85(6):1557\u201364.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1009_CR58","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1365-2230.2002.01076.x","volume":"27","author":"DH Rushton","year":"2002","unstructured":"Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396\u2013404.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"1009_CR59","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fertnstert.2014.01.003","volume":"101","author":"M Quinn","year":"2014","unstructured":"Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril. 2014;101(4):1129\u201334.","journal-title":"Fertil Steril"},{"key":"1009_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/767628","volume":"2014","author":"A Vujovic","year":"2014","unstructured":"Vujovic A, Del Marmol V. The female pattern hair loss: review of etiopathogenesis and diagnosis. Biomed Res Int. 2014;2014:767628.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1009_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-019-00479-x","volume":"21","author":"M Starace","year":"2020","unstructured":"Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21(1):69\u201384.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"1009_CR62","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233\u201357.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1009_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40257-014-0107-3","volume":"16","author":"J Brescoll","year":"2015","unstructured":"Brescoll J, Daveluy S. A review of vitamin B12 in dermatology. Am J Clin Dermatol. 2015;16(1):27\u201333.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"1009_CR64","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ncp.10321","volume":"34","author":"M DiBaise","year":"2019","unstructured":"DiBaise M, Tarleton SM. Hair, nails, and skin: differentiating cutaneous manifestations of micronutrient deficiency. Nutr Clin Pract. 2019;34(4):490\u2013503.","journal-title":"Nutr Clin Pract"},{"issue":"9","key":"1009_CR65","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1007\/s12011-020-02468-2","volume":"199","author":"IN Kondrakhina","year":"2021","unstructured":"Kondrakhina IN, Verbenko DA, Zatevalov AM, Gatiatulina ER, Nikonorov AA, Deryabin DG, et al. A cross-sectional study of plasma trace elements and vitamins content in androgenetic alopecia in men. Biol Trace Elem Res. 2021;199(9):3232\u201341.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"1009_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0022-202X.2004.23237.x","volume":"123","author":"IM Hadshiew","year":"2004","unstructured":"Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Investig Dermatol. 2004;123(3):455\u20137.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"1009_CR67","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","volume":"154","author":"A Freites-Martinez","year":"2018","unstructured":"Freites-Martinez A, Shapiro J, Chan D, Fornier M, Modi S, Gajria D, et al. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol. 2018;154(6):670\u20135.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1009_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4158\/EP.7.2.120","volume":"7","author":"NF Goodman","year":"2001","unstructured":"Goodman NF, Bledsoe MB, Cobin RH, Futterweit W, Goldzieher JW, Petak SM, et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract. 2001;7(2):120\u201334.","journal-title":"Endocr Pract"},{"issue":"3","key":"1009_CR69","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","volume":"97","author":"E Ludwig","year":"1977","unstructured":"Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247\u201354.","journal-title":"Br J Dermatol"},{"key":"1009_CR70","doi-asserted-by":"crossref","unstructured":"Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res. 2015;4(F1000 Faculty Rev):585.","DOI":"10.12688\/f1000research.6401.1"},{"issue":"2","key":"1009_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1067\/mjd.2003.81","volume":"48","author":"EA Olsen","year":"2003","unstructured":"Olsen EA. Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. J Am Acad Dermatol. 2003;48(2):253\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR72","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","volume":"53","author":"JB Hamilton","year":"1951","unstructured":"Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53(3):708\u201328.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1009_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.det.2012.08.007","volume":"31","author":"AJ Jackson","year":"2013","unstructured":"Jackson AJ, Price VH. How to diagnose hair loss. Dermatol Clin. 2013;31(1):21\u20138.","journal-title":"Dermatol Clin"},{"issue":"2","key":"1009_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0974-7753.58555","volume":"1","author":"A Rakowska","year":"2009","unstructured":"Rakowska A, Slowinska M, Kowalska-Oledzka E, Olszewska M, Rudnicka L. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichol. 2009;1(2):123\u201330.","journal-title":"Int J Trichol"},{"issue":"2","key":"1009_CR75","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jaad.2023.04.033","volume":"89","author":"R Pirmez","year":"2023","unstructured":"Pirmez R. The dermatoscope in the hair clinic: trichoscopy of scarring and nonscarring alopecia. J Am Acad Dermatol. 2023;89(2):S9\u201315.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR76","doi-asserted-by":"publisher","first-page":"415.e1","DOI":"10.1016\/j.jaad.2014.04.070","volume":"71","author":"T Mubki","year":"2014","unstructured":"Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination. J Am Acad Dermatol. 2014;71(3):415.e1-.e15.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR77","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jaad.2016.10.002","volume":"76","author":"KA McDonald","year":"2017","unstructured":"McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017;76(3):472\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000246049","volume":"194","author":"M Guarrera","year":"2009","unstructured":"Guarrera M, Semino MT, Rebora A. Quantitating hair loss in women: a critical approach. Dermatology. 2009;194(1):12\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"1009_CR79","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaad.2023.09.059","volume":"90","author":"MG Buontempo","year":"2024","unstructured":"Buontempo MG, Oh CS, Alhanshali L, Klein EJ, Karim M, Shapiro J, et al. Evaluating subjective versus objective measures of changes in hair density using standardized scalp photography. J Am Acad Dermatol. 2024;90(1):210\u20131.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1009_CR80","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1524-4725.2009.01105.x","volume":"35","author":"B Riedel-Baima","year":"2009","unstructured":"Riedel-Baima B, Riedel A. Use of the TrichoScan to assess female pattern hair loss. Dermatol Surg. 2009;35(4):651\u20135.","journal-title":"Dermatol Surg"},{"issue":"2","key":"1009_CR81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0974-7753.58553","volume":"1","author":"R Dhurat","year":"2009","unstructured":"Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichol. 2009;1(2):108\u201319.","journal-title":"Int J Trichol"},{"issue":"2s","key":"1009_CR82","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaad.2023.05.047","volume":"89","author":"LC Sperling","year":"2023","unstructured":"Sperling LC. The role of the scalp biopsy in the evaluation of alopecia. J Am Acad Dermatol. 2023;89(2s):S16\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2559.2009.03439.x","volume":"56","author":"CM Stefanato","year":"2010","unstructured":"Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology. 2010;56(1):24\u201338.","journal-title":"Histopathology"},{"issue":"7","key":"1009_CR84","first-page":"807","volume":"20","author":"E Kakpovbia","year":"2021","unstructured":"Kakpovbia E, Ugonabo N, Chen A, Adhikari S, Ogbechie-Godec OA, Sicco KL, et al. Impact of laboratory work up and supplementation on alopecia patients: a single-center retrospective chart review. J Drugs Dermatol. 2021;20(7):807\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"1009_CR85","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaad.2005.11.1104","volume":"54","author":"LB Trost","year":"2006","unstructured":"Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824\u201344.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1009_CR86","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11046-022-00678-x","volume":"188","author":"AT G\u00fcle\u00e7","year":"2023","unstructured":"G\u00fcle\u00e7 AT. Trichoscopic evaluation of tinea capitis. Mycopathologia. 2023;188(5):553\u201361.","journal-title":"Mycopathologia"},{"issue":"9","key":"1009_CR87","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJMra1901593","volume":"382","author":"KG Ghanem","year":"2020","unstructured":"Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. N Engl J Med. 2020;382(9):845\u201354.","journal-title":"N Engl J Med"},{"issue":"2","key":"1009_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000431314","volume":"231","author":"BM Piraccini","year":"2015","unstructured":"Piraccini BM, Broccoli A, Starace M, Gaspari V, D\u2019Antuono A, Dika E, et al. Hair and scalp manifestations in secondary syphilis: epidemiology, clinical features and trichoscopy. Dermatology. 2015;231(2):171\u20136.","journal-title":"Dermatology"},{"issue":"4","key":"1009_CR89","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-0041-1741037","volume":"54","author":"L Dhami","year":"2021","unstructured":"Dhami L. Psychology of hair loss patients and importance of counseling. Indian J Plast Surg. 2021;54(4):411\u20135.","journal-title":"Indian J Plast Surg"},{"issue":"1","key":"1009_CR90","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0277-9536(94)90311-5","volume":"38","author":"J Van Der Donk","year":"1994","unstructured":"Van Der Donk J, Hunfeld JA, Passchier J, Knegt-Junk KJ, Nieboer C. Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med. 1994;38(1):159\u201363.","journal-title":"Soc Sci Med"},{"issue":"3","key":"1009_CR91","doi-asserted-by":"publisher","first-page":"e2023139","DOI":"10.5826\/dpc.1303a139","volume":"13","author":"NE Mohamed","year":"2023","unstructured":"Mohamed NE, Soltan MR, Galal SA, El Sayed HS, Hassan HM, Khatery BH. Female pattern hair loss and negative psychological impact: possible role of brain-derived neurotrophic factor (BDNF). Dermatol Pract Concept. 2023;13(3):e2023139.","journal-title":"Dermatol Pract Concept."},{"issue":"5","key":"1009_CR92","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1468-3083.2002.00475.x","volume":"16","author":"FM Camacho","year":"2002","unstructured":"Camacho FM, Garc\u00eda-Hern\u00e1ndez M. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol. 2002;16(5):476\u201380.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1009_CR93","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1046\/j.1365-2133.2001.04195.x","volume":"144","author":"S Schmidt","year":"2001","unstructured":"Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol. 2001;144(5):1038\u201343.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1009_CR94","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1096\/fj.07-099424","volume":"22","author":"K Shorter","year":"2008","unstructured":"Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J. 2008;22(6):1725\u201336.","journal-title":"FASEB J"},{"issue":"2","key":"1009_CR95","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","volume":"150","author":"AG Messenger","year":"2004","unstructured":"Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186\u201394.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1009_CR96","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1346-8138.1990.tb01641.x","volume":"17","author":"O Mori","year":"1990","unstructured":"Mori O, Uno H. The effect of topical minoxidil on hair follicular cycles of rats. J Dermatol. 1990;17(5):276\u201381.","journal-title":"J Dermatol"},{"issue":"3","key":"1009_CR97","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archderm.1994.01690030035005","volume":"130","author":"RL DeVillez","year":"1994","unstructured":"DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol. 1994;130(3):303\u20137.","journal-title":"Arch Dermatol"},{"issue":"10","key":"1009_CR98","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-4362.1993.tb02755.x","volume":"32","author":"JP Jacobs","year":"1993","unstructured":"Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol. 1993;32(10):758\u201362.","journal-title":"Int J Dermatol"},{"issue":"6","key":"1009_CR99","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","volume":"65","author":"U Blume-Peytavi","year":"2011","unstructured":"Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65(6):1126-34.e2.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1009_CR100","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","volume":"50","author":"AW Lucky","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541\u201353.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR101","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1067\/mjd.2002.124088","volume":"47","author":"EA Olsen","year":"2002","unstructured":"Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1009_CR102","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatol Treat. 2022;33(4):1896\u2013906.","journal-title":"J Dermatol Treat"},{"issue":"11","key":"1009_CR103","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1111\/jocd.15138","volume":"21","author":"EJ Klein","year":"2022","unstructured":"Klein EJ, Karim M, Shapiro J, Sicco KL. Comparing combination low-dose oral minoxidil and topical minoxidil with oral minoxidil alone for the treatment of non-scarring alopecia: a retrospective chart review. J Cosmet Dermatol. 2022;21(11):6473\u20135.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1009_CR104","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s13555-023-00919-x","volume":"13","author":"Z Shadi","year":"2023","unstructured":"Shadi Z. Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatol Ther (Heidelb). 2023;13(5):1157\u201369.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"1009_CR105","doi-asserted-by":"publisher","first-page":"252","DOI":"10.36849\/JDD.6639","volume":"22","author":"A Senthilnathan","year":"2023","unstructured":"Senthilnathan A, Larrondo J, De Souza B, Harris T, Eginli A, McMichael A. Topical minoxidil adherence in patients with alopecia. J Drugs Dermatol. 2023;22(3):252\u20135.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"1009_CR106","doi-asserted-by":"publisher","first-page":"131","DOI":"10.36849\/JDD.8424","volume":"24","author":"S Kobayashi","year":"2025","unstructured":"Kobayashi S, Rose L, Minta A, Trovato S, Dulmage B. Comparing adherence, side effects, and satisfaction in oral and topical minoxidil: a cross-sectional study. J Drugs Dermatol. 2025;24(2):131\u20133.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"1009_CR107","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamadermatol.2024.0284","volume":"160","author":"MA Penha","year":"2024","unstructured":"Penha MA, Miot HA, Kasprzak M, M\u00fcller RP. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024;160(6):600\u20135.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"1009_CR108","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/jocd.16086","volume":"23","author":"A Asilian","year":"2024","unstructured":"Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: a randomized controlled trial. J Cosmet Dermatol. 2024;23(3):949\u201357.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"1009_CR109","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2232065","volume":"34","author":"S Va\u00f1\u00f3-Galv\u00e1n","year":"2023","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Bisanga CN, Bouhanna P, Farjo B, Gambino V, Meyer-Gonz\u00e1lez T, et al. An international expert consensus statement focusing on pre and post hair transplantation care. J Dermatol Treat. 2023;34(1):2232065.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"1009_CR110","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jaad.2024.01.089","volume":"91","author":"D Desai","year":"2024","unstructured":"Desai D, Nohria A, Sikora M, Mandal S, Shapiro J, Caplan AS, et al. Response to \u201cLow-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study.\u201d J Am Acad Dermatol. 2024;91(1):e11\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1009_CR111","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/ijd.17645","volume":"64","author":"D Desai","year":"2025","unstructured":"Desai D, Nohria A, Brinks AL, Needle CD, Sikora M, Anyanwu N, et al. Low-dose oral minoxidil in alopecia: evaluating blood pressure changes in patients with abnormal blood pressure-a retrospective study. Int J Dermatol. 2025;64(7):1315\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1009_CR112","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jaad.2024.10.057","volume":"92","author":"M Chen","year":"2025","unstructured":"Chen M, Weichert M, Guo W, Ruzic R, Briley J. Low-dose oral minoxidil does not significantly affect blood pressure: a systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(3):554\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR113","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaad.2023.10.010","volume":"90","author":"M Ong","year":"2024","unstructured":"Ong M, Do H, Ho B, Lipner SR. Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study. J Am Acad Dermatol. 2024;90(2):425\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1009_CR114","first-page":"742","volume":"21","author":"D Saceda-Corralo","year":"2022","unstructured":"Saceda-Corralo D, Moustafa F, Moreno-Arrones \u00d3, Ja\u00e9n-Olasolo P, Va\u00f1\u00f3-Galv\u00e1n S, Camacho F. Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice. J Drugs Dermatol. 2022;21(7):742\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 2","key":"1009_CR115","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1097\/00005344-198000022-00016","volume":"2","author":"WB Martin","year":"1980","unstructured":"Martin WB, Spodick DH, Zins GR. Pericardial disorders occurring during open-label study of 1,869 severely hypertensive patients treated with minoxidil. J Cardiovasc Pharmacol. 1980;2(Suppl 2):S217\u201327.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"1009_CR116","doi-asserted-by":"publisher","first-page":"725","DOI":"10.36849\/JDD.8029","volume":"23","author":"CM Kincaid","year":"2024","unstructured":"Kincaid CM, Sharma AN, Sargent B, Gradus-Pizlo I, Dineen EH, Mesinkovska NA. Evaluation of pericardial effusions in alopecia patients on low-dose oral minoxidil therapy. J Drugs Dermatol. 2024;23(9):725\u20138.","journal-title":"J Drugs Dermatol"},{"key":"1009_CR117","doi-asserted-by":"crossref","unstructured":"Zaminski D, Alhanshali L, Shapiro J, Caplan AS, Femia AN, Lo Sicco K, et al. Tolerability of Low-Dose Oral Minoxidil in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study. Int J Dermatol. 2025;64(9):1759\u201361.","DOI":"10.1111\/ijd.17734"},{"issue":"4","key":"1009_CR118","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaad.2023.10.072","volume":"91","author":"P McMullan","year":"2024","unstructured":"McMullan P, Yaghi M, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: an update\u2014part I: pregnancy. J Am Acad Dermatol. 2024;91(4):619\u201348.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1009_CR119","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/ijd.17940","volume":"64","author":"CD Needle","year":"2025","unstructured":"Needle CD, Brinks AL, Kearney CA, Rachko G, Bieber AK, Shapiro J, et al. Alopecia treatments in breastfeeding: safety and clinical considerations. Int J Dermatol. 2025;64(12):2215\u201334.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1009_CR120","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","volume":"83","author":"LJ Burns","year":"2020","unstructured":"Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol. 2020;83(1):276\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR121","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.det.2010.03.011","volume":"28","author":"D Rathnayake","year":"2010","unstructured":"Rathnayake D, Sinclair R. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatol Clin. 2010;28(3):611\u20138.","journal-title":"Dermatol Clin"},{"issue":"2","key":"1009_CR122","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaad.2021.07.048","volume":"86","author":"JF James","year":"2022","unstructured":"James JF, Jamerson TA, Aguh C. Efficacy and safety profile of oral spironolactone use for androgenic alopecia: a systematic review. J Am Acad Dermatol. 2022;86(2):425\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR123","first-page":"e91","volume":"23","author":"S Devjani","year":"2024","unstructured":"Devjani S, Ezemma O, Jothishankar B, Saberi S, Kelley KJ, Makredes SM. Efficacy of low-dose spironolactone for hair loss in women. J Drugs Dermatol. 2024;23(3):e91\u20132.","journal-title":"J Drugs Dermatol"},{"key":"1009_CR124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jdin.2024.07.023","volume":"17","author":"A Nohria","year":"2024","unstructured":"Nohria A, Desai D, Sikora M, Anyanwu N, Caplan A, Shapiro J, et al. Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: a retrospective review. JAAD Int. 2024;17:24\u20136.","journal-title":"JAAD Int."},{"issue":"9","key":"1009_CR125","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00403-024-03361-x","volume":"316","author":"DD Desai","year":"2024","unstructured":"Desai DD, Nohria A, Sikora M, Anyanwu N, Shapiro J, Lo Sicco KI. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. Arch Dermatol Res. 2024;316(9):622.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"1009_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.048","volume":"92","author":"J Jimenez-Cauhe","year":"2025","unstructured":"Jimenez-Cauhe J, Gil-Redondo R, Saceda-Corralo D, Imbernon-Moya A, Hermosa-Gelbard A, Ortega-Quijano D, et al. Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. J Am Acad Dermatol. 2025;92(6):e197-e8.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1009_CR127","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ad.2020.03.001","volume":"111","author":"P Vargas-Mora","year":"2020","unstructured":"Vargas-Mora P, Morgado-Carrasco D. Spironolactone in dermatology: uses in acne, hidradenitis suppurativa, female pattern baldness, and hirsutism. Actas Dermosifiliogr (Engl Ed). 2020;111(8):639\u201349.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"4","key":"1009_CR128","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijwd.2020.05.002","volume":"6","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lipner SR. Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration. Int J Womens Dermatol. 2020;6(4):272\u20136.","journal-title":"Int J Womens Dermatol"},{"issue":"5","key":"1009_CR129","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jaad.2024.07.1446","volume":"91","author":"J Lai","year":"2024","unstructured":"Lai J, Zaenglein AL, Barbieri JS. Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: a retrospective cohort study. J Am Acad Dermatol. 2024;91(5):982\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR130","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000083","volume":"9","author":"MG Buontempo","year":"2023","unstructured":"Buontempo MG, Alhanshali L, Shapiro J, Lo Sicco K. Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia. Int J Womens Dermatol. 2023;9(2):e083.","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"1009_CR131","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2021.5866","volume":"158","author":"K Bommareddy","year":"2022","unstructured":"Bommareddy K, Hamade H, Lopez-Olivo MA, Wehner M, Tosh T, Barbieri JS. Association of spironolactone use with risk of cancer: a systematic review and meta-analysis. JAMA Dermatol. 2022;158(3):275\u201382.","journal-title":"JAMA Dermatol"},{"issue":"7","key":"1009_CR132","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/ced.14292","volume":"45","author":"HY Sun","year":"2020","unstructured":"Sun HY, Sebaratnam DF. Clascoterone as a novel treatment for androgenetic alopecia. Clin Exp Dermatol. 2020;45(7):913\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"1009_CR133","first-page":"197","volume":"18","author":"C Rosette","year":"2019","unstructured":"Rosette C, Rosette N, Mazzetti A, Moro L, Gerloni M. Cortexolone 17\u03b1-propionate (Clascoterone) is an androgen receptor antagonist in dermal papilla cells in vitro. J Drugs Dermatol. 2019;18(2):197\u2013201.","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"1009_CR134","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","volume":"83","author":"S Devjani","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701\u201315.","journal-title":"Drugs"},{"key":"1009_CR135","unstructured":"A 6-month phase 3, multicenter, prospective, randomized, double-blind, vehicle-controlled study, to evaluate the efficacy and safety of topically applied clascoterone solution for the treatment of androgenetic alopecia in males, followed by a 6-month single-blind treatment with clascoterone or vehicle solution. In: Ergomed PLC, Pharmapace I, Canfield Scientific I, Research IC, editors. 2023."},{"issue":"7","key":"1009_CR136","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1080\/09546634.2022.2109567","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. J Dermatol Treat. 2022;33(7):2946\u201362.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"1009_CR137","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1529-8019.2011.01441.x","volume":"24","author":"A Rossi","year":"2011","unstructured":"Rossi A, Cantisani C, Scarn\u00f2 M, Trucchia A, Fortuna MC, Calvieri S. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10\u2010year follow\u2010up. Dermatol Ther. 2011;24(4):455\u201361.","journal-title":"Dermatol Ther"},{"issue":"5","key":"1009_CR138","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1067\/mjd.2000.107953","volume":"43","author":"VH Price","year":"2000","unstructured":"Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5):768\u201376.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR139","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5021\/ad.2012.24.3.370","volume":"24","author":"WJ Kim","year":"2012","unstructured":"Kim WJ, Song M, Ko HC, Kim BS, Kim MB. Efficacy of finasteride 1.25 mg on female pattern hair loss; pilot study. Ann Dermatol. 2012;24(3):370\u20132.","journal-title":"Ann Dermatol"},{"issue":"6","key":"1009_CR140","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4103\/0378-6323.144162","volume":"80","author":"IH Boersma","year":"2014","unstructured":"Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2014;80(6):521\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"1009_CR141","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000079890","volume":"209","author":"RM Tr\u00fceb","year":"2004","unstructured":"Tr\u00fceb RM. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology. 2004;209(3):202\u20137.","journal-title":"Dermatology"},{"issue":"3","key":"1009_CR142","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/archderm.142.3.298","volume":"142","author":"M Iorizzo","year":"2006","unstructured":"Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A. Finasteride treatment of female pattern hair loss. Arch Dermatol. 2006;142(3):298\u2013302.","journal-title":"Arch Dermatol"},{"issue":"3","key":"1009_CR143","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/09513590701214463","volume":"23","author":"C Kohler","year":"2007","unstructured":"Kohler C, Tschumi K, Bodmer C, Schneiter M, Birkhaeuser M. Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone. Gynecol Endocrinol. 2007;23(3):142\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1009_CR144","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","volume":"79","author":"E Carmina","year":"2003","unstructured":"Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003;79(1):91\u20135.","journal-title":"Fertil Steril"},{"issue":"2","key":"1009_CR145","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","volume":"25","author":"J Yeon","year":"2011","unstructured":"Yeon J, Jung J, Choi J, Kim B, Youn S, Park K, et al. 5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. J Eur Acad Dermatol Venereol. 2011;25(2):211\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1009_CR146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0974-7753.114709","volume":"5","author":"R Oliveira-Soares","year":"2013","unstructured":"Oliveira-Soares R, e Silva JM, Correia MP, Andr\u00e9 MC. Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women. Int J Trichol. 2013;5(1):22\u20135.","journal-title":"Int J Trichol"},{"issue":"5","key":"1009_CR147","first-page":"637","volume":"4","author":"M Olszewska","year":"2005","unstructured":"Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol. 2005;4(5):637\u201340.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"1009_CR148","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0378-6323.188652","volume":"83","author":"SJ Shanshanwal","year":"2017","unstructured":"Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017;83(1):47\u201354.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"1009_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13379","volume":"33","author":"R Dhurat","year":"2020","unstructured":"Dhurat R, Sharma A, Rudnicka L, Kroumpouzos G, Kassir M, Galadari H, et al. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. Dermatol Ther. 2020;33(3):e13379.","journal-title":"Dermatol Ther"},{"issue":"6","key":"1009_CR150","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","volume":"55","author":"EA Olsen","year":"2006","unstructured":"Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014\u201323.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR151","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2025.04.074","volume":"93","author":"MM Ong","year":"2025","unstructured":"Ong MM, Avram M, McMichael A, Tosti A, Lipner SR. Antiandrogen therapy for the treatment of female pattern hair loss: a clinical review of current and emerging therapies. J Am Acad Dermatol. 2025;93(3):749\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1009_CR152","first-page":"414","volume":"15","author":"LR Seale","year":"2016","unstructured":"Seale LR, Eglini AN, McMichael AJ. Side effects related to 5 \u03b1-reductase inhibitor treatment of hair loss in women: a review. J Drugs Dermatol. 2016;15(4):414\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"1009_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309849","volume":"20","author":"X Zhong","year":"2025","unstructured":"Zhong X, Yang Y, Wei S, Liu Y. Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) from 2004 to April 2024. PLoS ONE. 2025;20(3):e0309849.","journal-title":"PLoS ONE"},{"issue":"11","key":"1009_CR154","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3390\/jcm13113052","volume":"13","author":"SM Seyed Jafari","year":"2024","unstructured":"Seyed Jafari SM, Heidemeyer K, Hunger RE, de Viragh PA. Safety of antiandrogens for the treatment of female androgenetic alopecia with respect to gynecologic malignancies. J Clin Med. 2024;13(11):3052.","journal-title":"J Clin Med"},{"issue":"4","key":"1009_CR155","first-page":"550","volume":"41","author":"L Drake","year":"1999","unstructured":"Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR156","unstructured":"Feingold KR, Adler RA, Ahmed SF, et al. eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000."},{"issue":"3","key":"1009_CR157","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/sonc.2000.8110","volume":"16","author":"RE Gross","year":"2000","unstructured":"Gross RE. Breast cancer: risk factors, screening, and prevention. Semin Oncol Nurs. 2000;16(3):176\u201384.","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"1009_CR158","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1524-4741.2008.00665.x","volume":"15","author":"GF Schwartz","year":"2009","unstructured":"Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, et al. Proceedings of the international consensus conference on breast cancer risk, genetics, and risk management, April, 2007. Breast J. 2009;15(1):4\u201316.","journal-title":"Breast J"},{"issue":"3","key":"1009_CR159","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1009_CR160","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","volume":"237","author":"SE Singletary","year":"2003","unstructured":"Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474\u201382.","journal-title":"Ann Surg"},{"issue":"1","key":"1009_CR161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","volume":"174","author":"RN Rozner","year":"2019","unstructured":"Rozner RN, Freites-Martinez A, Shapiro J, Geer EB, Goldfarb S, Lacouture ME. Safety of 5\u03b1-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Breast Cancer Res Treat. 2019;174(1):15\u201326.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1009_CR162","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.jaad.2025.03.091","volume":"93","author":"CA Kearney","year":"2025","unstructured":"Kearney CA, Needle CD, Brinks AL, Shapiro J, Lacouture ME, Lo Sicco KI. Response to Venkatesh et al\u2019s \u201cAnalysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: a single-center retrospective cohort study.\u201d J Am Acad Dermatol. 2025;93(2):e73\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR163","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jaad.2024.09.028","volume":"92","author":"T Venkatesh","year":"2025","unstructured":"Venkatesh T, Quan VL, Li EB, Colavincenzo ML. Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: a single-center retrospective cohort study. J Am Acad Dermatol. 2025;92(1):163\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR164","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jaad.2024.10.023","volume":"92","author":"LC Chen","year":"2025","unstructured":"Chen LC, Hsieh TYJ, Senna MM. 5\u03b1-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: a population-based propensity score-matched cohort study. J Am Acad Dermatol. 2025;92(2):343\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR165","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/09546634.2020.1782324","volume":"33","author":"P Suchonwanit","year":"2022","unstructured":"Suchonwanit P, Iamsumang W, Leerunyakul K. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatol Treat. 2022;33(2):643\u20138.","journal-title":"J Dermatol Treat"},{"key":"1009_CR166","unstructured":"FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. April 22, 2025; Available from: https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded.  Accessed 22 Dec 2025."},{"issue":"3","key":"1009_CR167","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/09546639709160517","volume":"8","author":"GF Mazzarella","year":"1997","unstructured":"Mazzarella GF, Loconsole GF, Cammisa GA, Mastrolonardo GM, Vena GAG. Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course. J Dermatol Treat. 1997;8(3):189\u201392.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"1009_CR168","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","volume":"20","author":"P Suchonwanit","year":"2019","unstructured":"Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. Am J Clin Dermatol. 2019;20(1):147\u201353.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"1009_CR169","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5414\/CP202119","volume":"52","author":"M Caserini","year":"2014","unstructured":"Caserini M, Radicioni M, Leuratti C, Annoni O, Palmieri R. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther. 2014;52(10):842\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"1009_CR170","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","volume":"27","author":"N Moftah","year":"2013","unstructured":"Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, et al. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013;27(6):686\u201393.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR171","first-page":"1","volume-title":"xPharm: the comprehensive pharmacology reference","author":"SE Bicalutamide","year":"2007","unstructured":"Bicalutamide SE. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference. New York: Elsevier; 2007. p. 1\u20135."},{"key":"1009_CR172","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/B978-0-7020-7167-6.00046-4","volume-title":"Medical pharmacology and therapeutics","author":"DG Waller","year":"2018","unstructured":"Waller DG, Sampson AP. 46\u2014Androgens, antiandrogens and anabolic steroids. In: Waller DG, Sampson AP, editors. Medical pharmacology and therapeutics. 5th ed. Elsevier: Amsterdam; 2018. p. 531\u20135.","edition":"5"},{"key":"1009_CR173","volume-title":"Flutamide. StatPearls","author":"DB Johnson","year":"2025","unstructured":"Johnson DB, Sonthalia S. Flutamide. StatPearls. Treasure Island: StatPearls Publishing; 2025."},{"issue":"6","key":"1009_CR174","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13096","volume":"32","author":"D Fernandez-Nieto","year":"2019","unstructured":"Fernandez-Nieto D, Saceda-Corralo D, Rodrigues-Barata R, Hermosa-Gelbard A, Moreno-Arrones O, Jimenez-Cauhe J, et al. Oral bicalutamide for female pattern hair loss: a pilot study. Dermatol Ther. 2019;32(6):e13096.","journal-title":"Dermatol Ther"},{"issue":"5","key":"1009_CR175","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jaad.2020.03.034","volume":"83","author":"FF Ismail","year":"2020","unstructured":"Ismail FF, Meah N, de Trinda Carvalho L, Bhoyrul B, Wall D, Sinclair R. Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients. J Am Acad Dermatol. 2020;83(5):1478\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR176","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jdin.2024.12.002","volume":"19","author":"RDS Lib\u00f3rio","year":"2025","unstructured":"Lib\u00f3rio RDS, Motta AVD, Miot HA, M\u00fcller RP. Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind clinical trial. JAAD Int. 2025;19:48\u201355.","journal-title":"JAAD Int."},{"issue":"10","key":"1009_CR177","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1111\/jocd.14773","volume":"21","author":"RM Carvalho","year":"2022","unstructured":"Carvalho RM, Santos LDN, Ramos PM, Machado CJ, Acioly P, Frattini SC, et al. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. J Cosmet Dermatol. 2022;21(10):4171\u20135.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"1009_CR178","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40257-019-00493-z","volume":"21","author":"DH Marks","year":"2020","unstructured":"Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM. Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris. Am J Clin Dermatol. 2020;21(2):245\u201354.","journal-title":"Am J Clin Dermatol"},{"issue":"08","key":"1009_CR179","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/s-2007-1003337","volume":"24","author":"C Eil","year":"1992","unstructured":"Eil C. Ketoconazole binds to the human androgen receptor. Horm Metab Res. 1992;24(08):367\u201370.","journal-title":"Horm Metab Res"},{"issue":"4","key":"1009_CR180","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000017954","volume":"196","author":"C Pi\u00e9rard-Franchimont","year":"1998","unstructured":"Pi\u00e9rard-Franchimont C, De Doncker P, Cauwenbergh G, Pi\u00e9rard GE. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology. 1998;196(4):474\u20137.","journal-title":"Dermatology"},{"issue":"1","key":"1009_CR181","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0306-9877(03)00264-0","volume":"62","author":"BS Hugo Perez","year":"2004","unstructured":"Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Med Hypotheses. 2004;62(1):112\u20135.","journal-title":"Med Hypotheses"},{"key":"1009_CR182","doi-asserted-by":"crossref","unstructured":"Gupta AK, De Doncker P, Talukder M. Role of topical ketoconazole in therapeutic hair care beyond seborrhoeic dermatitis and dandruff. JEADV Clin Pract. 2025;4(4):710\u20138.","DOI":"10.1002\/jvc2.70026"},{"key":"1009_CR183","first-page":"43","volume":"43","author":"JV Lint","year":"1988","unstructured":"Lint JV, Doncker P, Woestenborghs R. Chronic use of 2 % ketoconazole shampoo in patients with seborrheic dermatitis and dandruff: ketoconazole plasma levels and safety. Curr Ther Res Clin Exp. 1988;43:43\u20137.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"1009_CR184","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-198814010-00002","volume":"14","author":"TK Daneshmend","year":"1988","unstructured":"Daneshmend TK, Warnock DW. Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet. 1988;14(1):13\u201334.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1009_CR185","first-page":"43","volume":"43","author":"J Van Lint","year":"1988","unstructured":"Van Lint J, De Doncker P, Woestenborghs R. Chronic use of 2 % ketoconazole shampoo in patients with seborrheic dermatitis and dandruff: ketoconazole plasma levels and safety. Curr Ther Res. 1988;43(1):43\u20137.","journal-title":"Curr Ther Res"},{"issue":"6","key":"1009_CR186","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/0190-9622(93)70282-X","volume":"29","author":"FW Danby","year":"1993","unstructured":"Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008\u201312.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1009_CR187","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jaad.2023.10.071","volume":"91","author":"M Yaghi","year":"2024","unstructured":"Yaghi M, McMullan P, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: an update\u2014part II: lactation. J Am Acad Dermatol. 2024;91(4):651\u201368.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR188","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13202","volume":"33","author":"JR Fields","year":"2020","unstructured":"Fields JR, Vonu PM, Monir RL, Schoch JJ. Topical ketoconazole for the treatment of androgenetic alopecia: a systematic review. Dermatol Ther. 2020;33(1):e13202.","journal-title":"Dermatol Ther"},{"issue":"2","key":"1009_CR189","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0022-4731(84)90138-9","volume":"20","author":"A Leake","year":"1984","unstructured":"Leake A, Chisholm GD, Habib FK. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. J Steroid Biochem. 1984;20(2):651\u20135.","journal-title":"J Steroid Biochem"},{"issue":"5","key":"1009_CR190","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1365-2133.1988.tb03474.x","volume":"119","author":"D Stamatiadis","year":"1988","unstructured":"Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol. 1988;119(5):627\u201332.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1009_CR191","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1046\/j.1365-2133.2003.05435.x","volume":"149","author":"RS Berger","year":"2003","unstructured":"Berger RS, Fu JL, Smiles KA, Turner CB, Schnell BM, Werchowski KM, et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol. 2003;149(2):354\u201362.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1009_CR192","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1467-2494.2002.00145.x","volume":"24","author":"C Pi\u00e9rard-Franchimont","year":"2002","unstructured":"Pi\u00e9rard-Franchimont C, Goffin V, Henry F, Uhoda I, Braham C, Pi\u00e9rard GE. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. Int J Cosmet Sci. 2002;24(5):249\u201356.","journal-title":"Int J Cosmet Sci"},{"issue":"5","key":"1009_CR193","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1610-0387.2007.06304.x","volume":"5","author":"RM Tr\u00fceb","year":"2007","unstructured":"Tr\u00fceb RM. Shampoos: ingredients, efficacy and adverse effects. JDDG J Dtsch Dermatol Ges. 2007;5(5):356\u201365.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"6","key":"1009_CR194","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000066452","volume":"15","author":"C Pi\u00e9rard-Franchimont","year":"2002","unstructured":"Pi\u00e9rard-Franchimont C, Goffin V, Decroix J, Pi\u00e9rard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15(6):434\u201341.","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"2","key":"1009_CR195","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0300-483X(75)90118-3","volume":"5","author":"D Howes","year":"1975","unstructured":"Howes D, Black JG. Comparative percutaneous absorption of pyrithiones. Toxicology. 1975;5(2):209\u201320.","journal-title":"Toxicology"},{"key":"1009_CR196","unstructured":"Commission Regulation (EU) 2021\/1902 of 29 October 2021 amending Annexes II, III and V to Regulation (EC) No 1223\/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction (Text with EEA relevance). In: Union E, editor. EUR-Lex; 2021."},{"key":"1009_CR197","unstructured":"OPINION ON Zinc Pyrithione (ZPT) (CAS No 13463-41-7)\u2014Submission III. In: Safety SCoC, editor. European Commission; 2020."},{"key":"1009_CR198","unstructured":"Supplements IoMUaNRCUCotFfEtSoD. Dietary supplements: a framework for evaluating safety. Washington (DC): National Academies Press (US); 2005."},{"issue":"6","key":"1009_CR199","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10068-019-00605-9","volume":"28","author":"Y Kwon","year":"2019","unstructured":"Kwon Y. Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. Food Sci Biotechnol. 2019;28(6):1599\u2013606.","journal-title":"Food Sci Biotechnol"},{"key":"1009_CR200","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.2147\/CCID.S435795","volume":"16","author":"HV Sudeep","year":"2023","unstructured":"Sudeep HV, Rashmi S, Jestin TV, Richards A, Gouthamchandra K, Shyamprasad K. Oral and topical administration of a standardized saw palmetto oil reduces hair fall and improves the hair growth in androgenetic alopecia subjects\u2014a 16-week randomized, placebo-controlled study. Clin Cosmet Investig Dermatol. 2023;16:3251\u201366.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"1009_CR201","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/039463201202500435","volume":"25","author":"A Rossi","year":"2012","unstructured":"Rossi A, Mari E, Scarno M, Garelli V, Maxia C, Scali E, et al. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol. 2012;25(4):1167\u201373.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"1009_CR202","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1464-410X.1990.tb07199.x","volume":"66","author":"BE Carbin","year":"1990","unstructured":"Carbin BE, Larsson B, Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol. 1990;66(6):639\u201341.","journal-title":"Br J Urol"},{"issue":"9","key":"1009_CR203","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/jocd.13976","volume":"20","author":"IM Ibrahim","year":"2021","unstructured":"Ibrahim IM, Hasan MS, Elsabaa KI, Elsaie ML. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: a randomized comparative trial. J Cosmet Dermatol. 2021;20(9):2867\u201373.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"1009_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/549721","volume":"2014","author":"YH Cho","year":"2014","unstructured":"Cho YH, Lee SY, Jeong DW, Choi EJ, Kim YJ, Lee JG, et al. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Altern Med. 2014;2014(1):549721.","journal-title":"Evid Based Complement Altern Med."},{"issue":"4","key":"1009_CR205","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15323","volume":"35","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Bamimore MA. Natural products for male androgenetic alopecia. Dermatol Ther. 2022;35(4):e15323.","journal-title":"Dermatol Ther"},{"issue":"5","key":"1009_CR206","doi-asserted-by":"publisher","first-page":"e1374","DOI":"10.1542\/peds.2011-2679","volume":"130","author":"M Miroddi","year":"2012","unstructured":"Miroddi M, Carn\u00ec A, Mannucci C, Moleti M, Navarra M, Calapai G. Hot flashes in a young girl: a wake-up call concerning Serenoa repens use in children. Pediatrics. 2012;130(5):e1374\u20136.","journal-title":"Pediatrics"},{"issue":"4","key":"1009_CR207","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0041-1739247","volume":"54","author":"RH True","year":"2021","unstructured":"True RH. Is every patient of hair loss a candidate for hair transplant? Deciding surgical candidacy in pattern hair loss. Indian J Plast Surg. 2021;54(4):435\u201340.","journal-title":"Indian J Plast Surg"},{"issue":"6\u20138","key":"1009_CR208","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14764172.2022.2088795","volume":"24","author":"R Memon","year":"2022","unstructured":"Memon R, Avram M. The pros and cons of follicular unit extraction (FUE) versus elliptical donor harvesting (FUT). J Cosmet Laser Ther. 2022;24(6\u20138):63\u20135.","journal-title":"J Cosmet Laser Ther"},{"issue":"4","key":"1009_CR209","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/jocd.16136","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin M, Zhang J, Jin Z, Pi L, Diao Y. Long-hair follicular unit excision enhances the cosmetic results of hairline restoration: a retrospective study in Chinese recipients. J Cosmet Dermatol. 2024;23(4):1344\u201350.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"1009_CR210","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.asj.2008.11.005","volume":"29","author":"S Salanitri","year":"2009","unstructured":"Salanitri S, Gon\u00e7alves AJ, Helene A Jr, Lopes FH. Surgical complications in hair transplantation: a series of 533 procedures. Aesthet Surg J. 2009;29(1):72\u20136.","journal-title":"Aesthet Surg J"},{"issue":"15","key":"1009_CR211","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00266-024-04166-z","volume":"48","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhao Y, Zhang J, Zhou Y, Yi Y, Lei R, et al. Risk factors and hazards of recipient-area perifollicular erythema after hair transplantation: a multicenter retrospective cohort study. Aesthet Plast Surg. 2024;48(15):2771\u20137.","journal-title":"Aesthet Plast Surg"},{"issue":"4","key":"1009_CR212","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1473-2165.2011.00582.x","volume":"10","author":"CK Wesley","year":"2011","unstructured":"Wesley CK, Unger RH, Rosenberg M, Unger MA, Unger WP. Factors influencing postoperative hyperesthesia in hair restoration surgery. J Cosmet Dermatol. 2011;10(4):301\u20136.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"1009_CR213","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.fsc.2020.01.003","volume":"28","author":"S Nadimi","year":"2020","unstructured":"Nadimi S. Complications with hair transplantation. Facial Plast Surg Clin North Am. 2020;28(2):225\u201335.","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"2","key":"1009_CR214","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1097\/SCS.0000000000009926","volume":"35","author":"JH Park","year":"2024","unstructured":"Park JH, Kim N, Manonukul K. Post-hair transplantation complication: kinky or severely curly hair. J Craniofac Surg. 2024;35(2):e146\u201350.","journal-title":"J Craniofac Surg"},{"issue":"5","key":"1009_CR215","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ad.2023.01.008","volume":"114","author":"JM Mir-Bonaf\u00e9","year":"2023","unstructured":"Mir-Bonaf\u00e9 JM, Mir-Bonaf\u00e9 JF, Mir-Bonaf\u00e9 M. Immediate-onset linear effluvium associated with high-density hair transplantation: a series of 28 cases. Actas Dermosifiliogr. 2023;114(5):437\u201341.","journal-title":"Actas Dermosifiliogr"},{"key":"1009_CR216","doi-asserted-by":"crossref","unstructured":"Brinks AL, Needle CD, Kearney CA, Singh M, Carre\u00f1o N, Osei-Tutu A, et al. Hair Transplant: Patient Candidacy, Medical Optimization, and Surgical Considerations. Int J Dermatol. 2026;65(2):245\u201356.","DOI":"10.1111\/ijd.17961"},{"issue":"3","key":"1009_CR217","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.fsc.2013.04.004","volume":"21","author":"RJ Konior","year":"2013","unstructured":"Konior RJ, Simmons C. Patient selection, candidacy, and treatment planning for hair restoration surgery. Facial Plast Surg Clin North Am. 2013;21(3):343\u201350.","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"4","key":"1009_CR218","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaad.2021.03.124","volume":"85","author":"F Jimenez","year":"2021","unstructured":"Jimenez F, Alam M, Vogel JE, Avram M. Hair transplantation: basic overview. J Am Acad Dermatol. 2021;85(4):803\u201314.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1009_CR219","first-page":"894","volume":"28","author":"MR Avram","year":"2002","unstructured":"Avram MR, Cole JP, Gandelman M, Haber R, Knudsen R, Leavitt MT, et al. The potential role of minoxidil in the hair transplantation setting. Dermatol Surg. 2002;28(10):894\u2013900.","journal-title":"Dermatol Surg"},{"issue":"0","key":"1009_CR220","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1684\/ejd.2023.4560","volume":"0","author":"L Zhao","year":"2023","unstructured":"Zhao L, Cao D. Application of hair transplantation combined with platelet-rich plasma injection for the treatment of androgenic alopecia. Eur J Dermatol. 2023;0(0):0.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"1009_CR221","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","volume":"19","author":"W Futterweit","year":"1988","unstructured":"Futterweit W, Dunaif A, Yeh H-C, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol. 1988;19(5):831\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1009_CR222","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2133.1982.tb01732.x","volume":"106","author":"JA Miller","year":"1982","unstructured":"Miller JA, Darley CR, Karkavitsas K, Kirby JD, Munro DD. Low sex-hormone binding globulin levels in young women with diffuse hair loss. Br J Dermatol. 1982;106(3):331\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1009_CR223","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ijd.12362","volume":"53","author":"B Buffoli","year":"2014","unstructured":"Buffoli B, Rinaldi F, Labanca M, Sorbellini E, Trink A, Guanziroli E, et al. The human hair: from anatomy to physiology. Int J Dermatol. 2014;53(3):331\u201341.","journal-title":"Int J Dermatol"},{"key":"1009_CR224","unstructured":"Martel JL, Miao JH, Badri T, et al. Anatomy, hair follicle. [Updated 2024 Jun 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470321\/. .  Accessed 8 Aug 2025."},{"issue":"9","key":"1009_CR225","first-page":"We01-3","volume":"9","author":"S Malkud","year":"2015","unstructured":"Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):We01-3.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"1009_CR226","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jaad.2023.12.079","volume":"91","author":"A Vander Does","year":"2024","unstructured":"Vander Does A, Larrondo J, McMichael A. Flambeau sign: a trichoscopic finding of traction alopecia in Black patients. J Am Acad Dermatol. 2024;91(4):e93\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1009_CR227","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1067\/mjd.2002.119104","volume":"46","author":"ES Friedman","year":"2002","unstructured":"Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46(2):309\u201312.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1009_CR228","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1009_CR229","first-page":"56","volume":"9","author":"JM Hirshburg","year":"2016","unstructured":"Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (Finasteride, Dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56\u201362.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"1009_CR230","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/14656566.2025.2461169","volume":"26","author":"AK Gupta","year":"2025","unstructured":"Gupta AK, Talukder M. Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review. Expert Opin Pharmacother. 2025;26(4):367\u201379.","journal-title":"Expert Opin Pharmacother"},{"key":"1009_CR231","unstructured":"AstraZeneca Pharmaceuticals LP. Casodex (bicalutamide) [package insert]. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/020498s028lbl.pdf. Revised October 2017. Accessed 5 Aug 2025."},{"key":"1009_CR232","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdrv.2025.03.005","volume":"4","author":"SM Perez","year":"2025","unstructured":"Perez SM, Nguyen B, Senna MM. Efficacy and safety of bicalutamide in female hair loss: a review of the literature. JAAD Rev. 2025;4:61\u20138.","journal-title":"JAAD Rev"},{"issue":"6","key":"1009_CR233","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0015-6264(79)90125-1","volume":"17","author":"GA Nolen","year":"1979","unstructured":"Nolen GA, Dierckman TA. Reproduction and teratology studies of zinc pyrithione administered orally or topically to rats and rabbits. Food Chem Toxicol. 1979;17(6):639\u201349.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"1009_CR234","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0041-008X(75)90265-3","volume":"31","author":"GA Nolen","year":"1975","unstructured":"Nolen GA, Patrick LF, Dierckman TA. A percutaneous teratology study of zinc pyrithione in rabbits. Toxicol Appl Pharmacol. 1975;31(3):430\u20133.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1009_CR235","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0041-008X(76)90005-3","volume":"36","author":"JH Wedig","year":"1976","unstructured":"Wedig JH, Kennedy GL Jr, Jenkins DH, Henderson R, Keplinger ML. Teratologic evaluation of dermally applied zinc pyrithione on swine. Toxicol Appl Pharmacol. 1976;36(2):255\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"1009_CR236","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1111\/jdv.17755","volume":"36","author":"R Tr\u00fceb","year":"2022","unstructured":"Tr\u00fceb R, Caballero\u2010Uribe N. Minoxidil\u2010induced hypertrichosis in a breastfed infant. J Eur Acad Dermatol Venereol. 2022;36(3):e224\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1009_CR237","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7326\/0003-4819-102-1-135_1","volume":"102","author":"A Valdivieso","year":"1985","unstructured":"Valdivieso A, Vald\u00e9s G, Spiro TE, Westerman RL. Minoxidil in breast milk. Ann Intern Med. 1985;102(1):135.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1009_CR238","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jaad.2008.11.896","volume":"61","author":"B Duque-Estrada","year":"2009","unstructured":"Duque-Estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol. 2009;61(4):707\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1009_CR239","first-page":"72","volume":"7","author":"R Kadry","year":"2008","unstructured":"Kadry R, Hamadah I, Al-Issa A, Field L, Alrabiah F. Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol. 2008;7(1):72\u20133.","journal-title":"J Drugs Dermatol"},{"key":"1009_CR240","unstructured":"Eligibility Criteria Alphabetical Listing. 2025; Available from: https:\/\/www.redcrossblood.org\/donate-blood\/how-to-donate\/eligibility-requirements\/eligibility-criteria-alphabetical.html.  Accessed 22 Dec 2025."},{"key":"1009_CR241","unstructured":"Anti-androgens. Donor selection guidelines: whole blood and components; Available from: https:\/\/www.transfusionguidelines.org\/dsg\/wb\/guidelines\/an027-anti-androgens#:~:text=Bicalutamide%20(Casodex%C2%AE)%2C%20cyproterone,used%20to%20treat%20male%20hypersexuality.  Accessed 22 Dec 2025."},{"key":"1009_CR242","unstructured":"Bicalutamide. Lexidrug: UpToDate.; Available from: https:\/\/www.uptodate.com\/contents\/bicalutamide-drug-information.  Accessed 22 Dec 2025."},{"key":"1009_CR243","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jdin.2022.08.013","volume":"9","author":"EJ Klein","year":"2022","unstructured":"Klein EJ, Karim M, Li X, Adhikari S, Shapiro J, Lo Sicco K. Supplementation and hair growth: a retrospective chart review of patients with alopecia and laboratory abnormalities. JAAD Int. 2022;9:69\u201371.","journal-title":"JAAD Int"},{"key":"1009_CR244","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.eclinm.2023.102286","volume":"65","author":"HK von Siebenthal","year":"2023","unstructured":"von Siebenthal HK, Gessler S, Vallelian F, Steinwendner J, Kuenzi U-M, Moretti D, et al. Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. EClinicalMedicine. 2023;65:102286.","journal-title":"EClinicalMedicine."},{"issue":"8","key":"1009_CR245","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/dsu.12200","volume":"39","author":"H Kim","year":"2013","unstructured":"Kim H, Choi JW, Kim JY, Shin JW, Lee S-j, Huh C-H. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device\u2014controlled multicenter trial. Dermatol Surg. 2013;39(8):1177\u201383.","journal-title":"Dermatol Surg"},{"issue":"2","key":"1009_CR246","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","volume":"15","author":"JJ Jimenez","year":"2014","unstructured":"Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115\u201327.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"1009_CR247","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/lsm.22684","volume":"49","author":"SM Esmat","year":"2017","unstructured":"Esmat SM, Hegazy RA, Gawdat HI, Abdel Hay RM, Allam RS, El Naggar R, et al. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study. Lasers Surg Med. 2017;49(9):835\u201343.","journal-title":"Lasers Surg Med"},{"issue":"5","key":"1009_CR248","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jaad.2020.06.1021","volume":"83","author":"DP Dubin","year":"2020","unstructured":"Dubin DP, Lin MJ, Leight HM, Farberg AS, Torbeck RL, Burton WB, et al. The effect of platelet-rich plasma on female androgenetic alopecia: a randomized controlled trial. J Am Acad Dermatol. 2020;83(5):1294\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1009_CR249","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jaad.2020.07.006","volume":"83","author":"J Shapiro","year":"2020","unstructured":"Shapiro J, Ho A, Sukhdeo K, Yin L, Lo Sicco K. Evaluation of platelet-rich plasma as a\u00a0treatment for androgenetic alopecia: a\u00a0randomized controlled trial. J Am Acad Dermatol. 2020;83(5):1298\u2013303.","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR250","doi-asserted-by":"crossref","unstructured":"Brinks A, Desai DD, Kearney CA, Needle C, Anyanwu N, Nohria A, et al. Impact of age on response to platelet-rich plasma therapy. Skin Appendage Disord. 2025 (online ahead of print).","DOI":"10.1159\/000546800"},{"issue":"11","key":"1009_CR251","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1111\/jocd.16459","volume":"23","author":"X Li","year":"2024","unstructured":"Li X, Zhang S. Progress of clinical research on fractional laser treatment of androgenetic alopecia: a review article. J Cosmet Dermatol. 2024;23(11):3456\u201365.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1009_CR252","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/jps.23485","volume":"102","author":"GM Gelfuso","year":"2013","unstructured":"Gelfuso GM, Gratieri T, Delgado-Charro MB, Guy RH, Vianna Lopez RF. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. J Pharm Sci. 2013;102(5):1488\u201394.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1009_CR253","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1103a82","volume":"11","author":"AM Alessandrini","year":"2021","unstructured":"Alessandrini AM, Bruni F, Piraccini BM, Starace M. The effectiveness and tolerability of preformed growth factors vehiculated through iontophoresis on patients with androgenetic alopecia and telogen effluvium: a clinical study. Dermatol Pract Concept. 2021;11(3):e2021082.","journal-title":"Dermatol Pract Concept"},{"issue":"11","key":"1009_CR254","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s13555-025-01532-w","volume":"15","author":"S Cedirian","year":"2025","unstructured":"Cedirian S, Pampaloni F, Quadrelli F, Rapparini L, Bruni F, Martelli G, et al. Efficacy of skin patting and iontophoresis with dutasteride gel in male and menopausal female androgenetic alopecia: a pilot study. Dermatol Ther. 2025;15(11):3419\u201324.","journal-title":"Dermatol Ther"},{"issue":"5","key":"1009_CR255","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bjd.13230","volume":"171","author":"A Ishino","year":"2014","unstructured":"Ishino A, Takahashi T, Suzuki J, Nakazawa Y, Iwabuchi T, Tajima M. Contribution of hair density and hair diameter to the appearance and progression of androgenetic alopecia in Japanese men. Br J Dermatol. 2014;171(5):1052\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1009_CR256","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2133.2010.09867.x","volume":"163","author":"BH Miranda","year":"2010","unstructured":"Miranda BH, Tobin DJ, Sharpe DT, Randall VA. Intermediate hair follicles: a new more clinically relevant model for hair growth investigations. Br J Dermatol. 2010;163(2):287\u201395.","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01009-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01009-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01009-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:01:53Z","timestamp":1774699313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-026-01009-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":256,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01009-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Lo Sicco is an investigator for Pfizer, consultant for Pfizer, Veradermics, and Acquis, and board member of the Scarring Alopecia Foundation and American Hair Research Society. Dr Shapiro is an investigator for Pfizer and consultant for Pfizer, Lilly, Replicel Life Science, Regen Lab, Thirty Madison, DS Laboratories, and Almirall. Authors Kearney, Brinks, Needle Lawrence, Maas, Spindler, Coric, Gener-Pangilinan, and Lasheras-P\u00e9rez have no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Conceptualization: KIL; Literature review: CAK, ALB, CNL, DEM, AJS, CC, LAG, MAL; Drafting of the manuscript: CAK, ALB, CNL, DEM, AJS, CC, LAG, MAL; Critical revision of the manuscript: CAK, ALB, CNL, JS, KIL; Supervision: KIL. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution statement"}}]}}